Startling information about the dangers of acetaminophen-based products such as the popular pain-killers Tylenol and Tylenol Plus are widely available to consumers and clearly document the dangerous links between the medications and liver failure.
One valuable source is our court system, where victims of this life-threatening side effect have filed Tylenol liver failure lawsuits detailing the devastating health problems they and loved ones have suffered from acetaminophen use.
For decades Tylenol products have ranked among the best-selling medications ever put on pharmacy shelves, generating billions of dollars in sales for the manufacturer. Even so, it was not until 2009 that the U.S. Food and Drug Administration, which initially sanctioned the products as safe, finally acknowledged that that even when taken in prescribed doses, these products can destroy the liver.
Even then, the drug’s manufacturer, Johnson & Johnson subsidiary McNeil, fought tooth and nail to avoid having to place the specific words “severe liver damage” on its warning labels, as directed by FDA regulators.
Corporate profits at stake
That a company would battle so hard to avoid warning consumers about a dangerous side effect that could cause their death speaks volumes about how pharmaceutical giants place corporate profits above consumer safety.
That morality is at the center of the allegations that are being made in Tylenol liver failure lawsuits. In reviewing the complaints that have been filed by victims of these side effects you come away with feelings of concern and sympathy for the health problems and deaths caused by these side effects.
You will also come away with an understanding of the basis of these lawsuits, which is that Tylenol and other acetaminophen-based medications were put on pharmacy shelves in a manner that put at risk the health of consumers.
Consumers inadequately warned
The Tylenol liver failure lawsuits accuse the manufacturers of knowing that the use of these products — even in recommended dosages — could cause liver failure and failing to adequately warn patients and federal regulators of these facts.
The Tylenol liver failure lawsuits also question whether there was adequate testing and screening of these risks and whether the manufacturers should have initiated earlier safety recalls than they did in certain instances.
There were certainly warning signs along the way, warning signs that Tylenol lawsuits claim were ignored or disregarded by the drug manufacturers. Many of you may be too young to remember the first Tylenol recall in 1982, which generated national headlines because of Extra-Strength Tylenol that contained cyanide. Over 31 million bottles of the product were recalled in the first week of that recall.